RealPeopleGroup Altamira Therapeutics ( NASDAQ: CYTO ) shares rallied 45% Thursday after the company said that a video highlighting a clinical trial for its drug Bentrio in the treatment of seasonal allergic rhinitis has been posted on the social media channels of the journal Allergy . The drug developer said the video can be found on Allergy’s channels on YouTube, Facebook, Twitter and LinkedIn. Altamira said it hopes to conclude negotiations during the course of the year with potential partners for distribution of the product in the U.
S. Europe and other key markets. More on Altamira Therapeutics Altamira Therapeutics Ltd.
2023 Q4 - Results - Earnings Call Presentation Altamira Therapeutics Ltd. (CYTO) Q4 2023 Earnings Call Transcript Altamira reports publication of positive results from NASAR clinical trial with Bentrio Altamira stock rallies 44% on Univercells mRNA collaboration Seeking Alpha’s Quant Rating on Altamira Therapeutics.
